Unicycive Therapeutics Inc Sustainability Reports

Unicycive Therapeutics Inc. is a biotechnology company focused on developing innovative treatments for kidney diseases.

Sector: Health Care

Country: United States

Exchange: Nasdaq Stock Market

ISIN: US90466Y1038

3 reports from 2022 to 2024

Company Profile

Unicycive Therapeutics Inc

Unicycive Therapeutics Inc. is a biotechnology company focused on developing innovative treatments for kidney diseases.

MIC

 

Ticker

 

ISIN

 

Website

www.unicycive.com

Country

United States

Exchange

Nasdaq Stock Market

Sector

Health Care

Industry

Pharmaceuticals, Biotechnology & Life Sciences

Reports

Available reports